FDA Approves First Buprenorphine Implant for Treatment of Opioid Dependence
The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low-level dose of buprenorphine for six months in patients who are already stable […]
FDA Approves First Buprenorphine Implant for Treatment of Opioid Dependence Read More »